Showing results (91-100 of 216) with videos related to
Sort By:
Pageof 22
Journal of Clinical Microbiology|October 1, 1986
Cefixime disk susceptibility test criteriaP C Fuchs, A L Barry, R N JonesJournal of Clinical Microbiology|June 1, 1988
Evaluation of in vitro methods for testing susceptibility of anaerobes to ampicillin-sulbactam and amoxicillin-clavulanic acidP C Fuchs, A L Barry, R N JonesBurns : Journal of the International Society for Burn Injuries|May 18, 2004
Is high PEEP low volume ventilation in burn patients beneficial? A retrospective study of 61 patientsT P Wolter, P C Fuchs, N Horvat, et al.Journal of Clinical Microbiology|September 1, 1986
Tentative disk diffusion susceptibility interpretive criteria for pefloxacinP C Fuchs, A L Barry, R N Jones, et al.Journal of Clinical Microbiology|March 1, 1986
Tentative disk diffusion susceptibility interpretive criteria for BMY-28142, a new cephalosporinP C Fuchs, R N Jones, A L Barry, et al.Diagnostic Microbiology and Infectious Disease|January 1, 1984
Temocillin: in vitro activity against 734 selected clinical isolates, including beta-lactamase-producing strainsP C Fuchs, A L Barry, R N Jones, et al.Antimicrobial Agents and Chemotherapy|March 1, 1986
LY164846 in vitro antimicrobial activity testing, including disk diffusion susceptibility tests using 30-microgram disksR N Jones, C Baker, A L Barry, et al.European Journal of Clinical Microbiology|February 1, 1985
Interpretive criteria for temocillin disk diffusion susceptibility testingP C Fuchs, A L Barry, C Thornsberry, et al.Diagnostic Microbiology and Infectious Disease|May 1, 1985
Evaluation of in vitro antibacterial activity of enoxacin: comparison with other orally absorbed antimicrobial agents, proposed disk diffusion test interpretive criteria, and quality control limitsP C Fuchs, A L Barry, R N Jones, et al.Journal of Clinical Microbiology|December 1, 1985
Cefotiam susceptibility testing criteriaP C Fuchs, A L Barry, R N Jones, et al.Pageof 22